Cargando…

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis

Background: Association between statin use and prognosis in patients with hepatocellular carcinoma (HCC) remains unknown. We performed a meta-analysis of follow-up studies to systematically evaluate the influence of statin use on clinical outcome in HCC patients. Methods: Studies were obtained via s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaofei, Liu, Liwen, Hu, Yongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133516/ https://www.ncbi.nlm.nih.gov/pubmed/32162652 http://dx.doi.org/10.1042/BSR20200232

Ejemplares similares

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta‐analysis
por: Li, Yue, et al.
Publicado: (2019)

Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017)

The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Liu, Jingjing, et al.
Publicado: (2019)

Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Qingqing, et al.
Publicado: (2020)

A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
por: Wang, Yikai, et al.
Publicado: (2022)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
por: Ge, Zijun, et al.
Publicado: (2019)

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
por: Pradelli, Danitza, et al.
Publicado: (2015)

Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
por: Islam, Md. Mohaimenul, et al.
Publicado: (2020)

Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta‐analysis
por: Huang, Xin, et al.
Publicado: (2019)

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis
por: Qin, Yuan, et al.
Publicado: (2021)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects
por: Zhang, Sheng, et al.
Publicado: (2020)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

Prognostic significance of the systemic immune‐inflammation index in pancreatic carcinoma patients: a meta-analysis
por: Li, Xiaocheng, et al.
Publicado: (2021)

Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
por: Huang, Jian, et al.
Publicado: (2020)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
por: Kohla, Mohamed A S, et al.
Publicado: (2015)

Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
por: Seo, Seung In, et al.
Publicado: (2021)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
por: Li, Xiaofei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l8ca7jdqaop7vggtjh9fubl3op